Skip to content

Application

detection of bioavailable copper in serum for diagnostic purposes

There is a clear need for improved precision for detection of bioavailable copper in serum for diagnostic purposes

Cu-sensor

ultrasensitive detection of bioavailable copper in serum and urine

Nanopore-based detection of bioavailable “free” Cu(II)

Two different detection principals are employed:

1. Fluorescence detection with a range of 13.5 nM- 60 µM

2. Ion Flow (I-V) detection with a sensitivity down to 10 femto molar Cu(II) concentrations , linear over seven orders of magnitude

(PCT application has been filled in January 2019 – currently in national phase EU, USA)